← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

▼ SELL

$ Value

$3.8M

Shares

40,985

Price

$92

Filed

Mar 17

Insider

Name

Peetz Christopher

Title

CHIEF EXECUTIVE OFFICER

CIK

0001614740

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

194,309

Footnotes

Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. | Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units. | The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. | The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.

Filing Info

Accession No.

0001614740-26-000009

Form Type

4

Issuer CIK

0001759425

Peetz Christopher's History

Date Ticker Type Value
2026-03-16 MIRM $3.8M
2026-03-15 MIRM M
2026-03-15 MIRM M
2026-03-15 MIRM M $0
2026-03-15 MIRM M $0
2026-02-02 MIRM $941K
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-26 MIRM $657K

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$772K 2026-03-16
Ramasastry Saira $580K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-03-15
Radovich Peter
PRESIDENT AND COO
$2.1M 2026-03-16
Quan Joanne
CHIEF MEDICAL OFFICER
$670K 2026-03-16
Howe Jolanda
SVP, GLOBAL CONTROLLER
$616K 2026-03-16